Compare Ravinder Heights with Similar Stocks
Total Returns (Price + Dividend) 
Ravinder Heights for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Ravinder Heights Ltd Valuation Shifts to Fair Amid Market Downturn
Ravinder Heights Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade amid a challenging market backdrop. The company’s price-to-earnings (P/E) ratio now stands at 4.36, significantly below sector averages, while its price-to-book value (P/BV) has compressed to 0.61, reflecting changing investor perceptions and a reassessment of its growth prospects within the realty sector.
Read full news article
Ravinder Heights Ltd is Rated Sell
Ravinder Heights Ltd is rated Sell by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Ravinder Heights Ltd Stock Falls to 52-Week Low Amid Market Pressure
Ravinder Heights Ltd, a player in the realty sector, has recently touched its 52-week low, marking a significant decline in its share price to ₹51.20. This new low reflects ongoing pressures on the stock, which has underperformed both its sector and the broader market over the past year.
Read full news article Announcements 
Disclosure Of Event Or Information Under Regulation 30 Of SEBI (LODR) Regulations 2015
02-Mar-2026 | Source : BSEIt is to inform the exchange that NSE and BSE has imposed fine under Regulation 17(1A) of SEBI (LODR) Regulation 2015 for the Quarter ended December 31 2025.
Updates- Machine Readable Form / Legible Copy Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2025
02-Mar-2026 | Source : BSEUpdates-Machine Readable Form/Legible Copy of Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine Months Ended December 31 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
14-Feb-2026 | Source : BSEPublication of newspaper extract of Unaudited Financial Results (standalone & consolidated) for the quarter & nine months ended 31st December 2025.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Sunanda Jain (74.74%)
Serum Institute Of India Private Limited (4.58%)
16.38%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -63.62% vs 42,215.38% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -68.70% vs 7,767.31% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 18,280.00% vs -6.25% in Sep 2024
Growth in half year ended Sep 2025 is 8,472.34% vs -135.00% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 16,979.55% vs -6.38% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 3,299.38% vs 11.96% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -8.06% vs -94.85% in Mar 2024
YoY Growth in year ended Mar 2025 is -18.14% vs -134.85% in Mar 2024






